Document is current
Any future updates will be listed below
-
Authors
Diamond, Akiva https://orcid.org/0000-0003-0184-2640
Vu, Long
Bensken, Wyatt P.
Koroukian, Siran M.
Caimi, Paolo F.
-
Funding
Funding for this research was provided by:
Case Comprehensive Cancer Center, Case Western Reserve University (P30 CA043703)
- License Information
-
More Information
Article History
Received: 16 December 2022
Revised: 18 April 2023
Accepted: 21 April 2023
First Online: 23 May 2023
Competing interests
: AD, WB, WD, LV do not have relevant conflicts to report. In the past 36 months, WB, LV, and SMK were supported by grants from the National Cancer Institute, Case Comprehensive Cancer Center (P30 CA043703); SMK was also supported by a grant from the American Cancer Society (132678-RSGI-19-213-01-CPHPS), and by contracts from Cleveland Clinic Foundation, including a subcontract from Celgene Corporation. Additional sources of support for Dr. Koroukian include grants from the National Institutes of Health (R15 NR017792, and UH3-DE025487) and the American Cancer Society (RWIA-20-111-02 RWIA). PFC reports grants from ADC Therapeutics SA and Genentech, consulting fees from Genentech, ADC Therapeutics, Kite Pharmaceuticals, Verastem, Seattle Genetics, Amgen, TG Therapeutics, Celgene.
